Journals / Ankara Medical Journal / 2020 / Cilt: 20 - Sayı: 4

Frailty Syndrome in the Elderly and Omega-3 Polyunsaturated Fatty Acids

Yaşlılarda Kırılganlık Sendromu ve Omega-3 ÇokluDoymamış Yağ Asitleri

Pages
1099–1111
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All studies emphasize the importance ofroutinely controlling nutritional status and making the necessary dietary interventions to prevent thedevelopment of sarcopenia and frailty.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Frailty syndrome is one of the most important problems of the aging population.
📊
Key Findings & Data:Omega-3 polyunsaturated fatty acid (PUFA) is known to have beneficial effects in the elderly withacute or chronic diseases due to its anti-inflammatory effect.
💡
Conclusion & Impact:All studies emphasize the importance ofroutinely controlling nutritional status and making the necessary dietary interventions to prevent thedevelopment of sarcopenia and frailty.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Frailty syndrome is one of the most important problems of the aging population. Various pathophysiologicalfactors constitute the pathophysiology of the syndrome, including dysregulation of inflammatory processes,oxidative stress, mitochondrial dysfunction, and cellular aging. Sociodemographic characteristics,psychological conditions, nutritional status, lack of physical activity, and existing comorbidities are factors thataffect frailty. Omega-3 polyunsaturated fatty acid (PUFA) is known to have beneficial effects in the elderly withacute or chronic diseases due to its anti-inflammatory effect. The purpose of this review is to examine andevaluate the evidence for the role of dietary or supplemental omega-3 PUFA in muscle mass and musclestrength, inflammatory biomarkers, and functional capacity in elderly individuals. Studies support that omega 3 PUFA may improve the course of the syndrome in pre-frailty older adults. The effects of dietary orsupplemental omega-3 PUFA in frail elderly are controversial. All studies emphasize the importance ofroutinely controlling nutritional status and making the necessary dietary interventions to prevent thedevelopment of sarcopenia and frailty.

Özet

Kırılganlık sendromu, yaşlanan nüfusun en önemli sorunlarından biridir. İnflamatuar süreçlerin düzensizliği, oksidatif stres, mitokondriyal işlev bozukluğu ve hücresel yaşlanma dahil olmak üzere çeşitli patofizyolojik etkenler, sendromun patofizyolojisini oluşturur. Sosyodemografik özellikler, psikolojik durumlar, beslenme durumu, fiziksel aktivite eksikliği ve mevcut komorbiditeler kırılganlığı etkileyen faktörlerdir. Omega-3 çoklu doymamış yağ asidinin (ÇDYA) akut veya kronik hastalığı olan yaşlılarda anti-inflamatuar etkisi sayesinde yararlı etkilerinin olduğu bilinmektedir. Bu derlemenin amacı, diyet kaynaklı veya destek olarak verilen omega-3 ÇDYA'nın yaşlı bireylerde kas kütlesi ve kas gücü, inflamatuar biyobelirteçler ve fonksiyonel kapasitedeki rolüne ilişkin kanıtları incelemek ve değerlendirmektir. Yapılan araştırmalar, omega-3 ÇDYA'nın pre-kırılganlık dönemde olan yaşlı bireylerde sendromun seyrini iyileştirici etki gösterebileceğini desteklemektedir. Kırılganlık evresinde olan yaşlılarda diyet kaynaklı veya destek olarak verilen omega-3 ÇDYA'nın etkileri tartışmalıdır. Tüm araştırmalar, sarkopeni ve kırılganlık gelişimini önlemek için rutin olarak beslenme durumunun kontrol edilmesi ve gerekli diyet müdahalelerinin yapılmasının önemini vurgulamaktadır.

🔖

Cite This Article

BÜYÜKUSLU, N., CİN, P. (2022). Frailty Syndrome in the Elderly and Omega-3 Polyunsaturated Fatty Acids. Ankara Medical Journal, Cilt: 20 - Sayı: 4, 1099–1111. https://ajindex.com/articles/441772

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing 2019 [İnternet]. https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAg eing2019-Highlights.pdf (Erişim tarihi: 11.11.2020
  2. Bauer JM, Sieber CC. Sarcopenia and frailty: A clinician’s controversial point of view. Exp Gerontol 2008;43(7):674-8
  3. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. Journals Gerontol Ser A Biol Sci Med Sci 2004;59(3):M255-63
  4. Fried LP, Tangen CM, Walston J, et al. Frailty in Older Adults: Evidence for a Phenotype. Journals Gerontol Ser A Biol Sci Med Sci 2001;56(3):M146-57
  5. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013;381(9868):752- 62
  6. Ak S, Maz MM, Mucuk S. The prevalence of frailty and related factors in community- dwelling Turkish elderly according to modified Fried Frailty Index and FRAIL scales. Aging Clin Exp Res 2015;27(5):703- 9
  7. Ateş Akbulut E, Kosuva Öztürk Z. Ayaktan Kliniğe Başvuran 60 Yaş Üstündeki Hastalarda Geriatrik Sendrom Prevalansı. Geriatrik Bilimler Dergisi 2018;1(1):8-13
  8. Eyigor S, Kutsal YG, Duran E, et al. Frailty prevalence and related factors in the older adult — FrailTURK Project. Age (Dordr) 2015;37(3):9791
  9. Viña J, Tarazona-Santabalbina FJ, Pérez-Ros P, et al. Biology of frailty: Modulation of ageing genes and its importance to prevent age-associated loss of function. Mol Aspects Med 2016;50:88-108
  10. Chen X, Mao G, Leng SX. Frailty syndrome: An overview. Clin Interv Aging 2014;9:433-41
  11. Lorenzo-López L, Maseda A, De Labra C, et al. Nutritional determinants of frailty in older adults: A systematic review. BMC Geriatr 2017;17(1):1-13
  12. Uzdil Z, Saka M. Yağ Asitlerinin İnflamasyonla İlişkili Süreçlere Etkisinin Değerlendirilmesi. Bes Diy Derg 2020;48(2):68-74
  13. Saini RK, Keum Y. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review. Life Sci 2018;203:255-67
  14. Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature 2010;464(7288):529-35
  15. Luo X, Ding J, Chen SD. Microglia in the aging brain: relevance to neurodegeneration. Mol Neurodegener 2010;5:12
  16. Van Munster BC, Aronica E, Zwinderman AH, et al. Neuroinflammation in delirium: A postmortem casecontrol study. Rejuvenation